In vitro and in vivo characterisation of ASP9521: a novel, selective, orally bioavailable inhibitor of 17β-hydroxysteroid dehydrogenase type 5 (17βHSD5; AKR1C3)

Autor: Kikuchi, Aya, Furutani, Takashi, Azami, Hidenori, Watanabe, Kazushi, Niimi, Tatsuya, Kamiyama, Yoshiteru, Kuromitsu, Sadao, Baskin-Bey, Edwina, Heeringa, Marten, Ouatas, Taoufik, Enjo, Kentaro
Zdroj: Investigational New Drugs; Oct2014, Vol. 32 Issue 5, p860-870, 11p
Databáze: Complementary Index
Externí odkaz: